Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khandan Keyomarsi

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Oncotarget|January 21, 2017
Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancerAngela Alexander, Cansu Karakas, Xian Chen, et al.
Nature Communications|January 3, 2024
Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistanceHyemin Lee, Amber Horbath, Lavanya Kondiparthi, et al.
Cancer Research|June 29, 2023
Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast CancersJuliana Navarro-Yepes, Nicole M Kettner, Xiayu Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2016
Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast CancerKelly K Hunt, Cansu Karakas, Min Jin Ha, et al.
Nature Communications|June 28, 2017
CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancersSmruthi Vijayaraghavan, Cansu Karakas, Iman Doostan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2023
Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing CancersTimothy P DiPeri, Kurt W Evans, Maria Gabriela Raso, et al.
Genome Research|December 24, 2017
Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesisHector L Franco, Anusha Nagari, Venkat S Malladi, et al.
Cancer Research|August 26, 2024
Low-Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast CancerMi Li, Amriti R Lulla, Yan Wang, et al.
Cancer Research|June 30, 2022
CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2Haoyan Li, Yin Wang, Kevin Lin, et al.
Cancer Research|January 5, 2023
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real TimeTuyen Duong Thanh Nguyen, Yan Wang, Tuyen N Bui, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Oncotarget|January 21, 2017
Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancerAngela Alexander, Cansu Karakas, Xian Chen, et al.
Nature Communications|January 3, 2024
Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistanceHyemin Lee, Amber Horbath, Lavanya Kondiparthi, et al.
Cancer Research|June 29, 2023
Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast CancersJuliana Navarro-Yepes, Nicole M Kettner, Xiayu Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2016
Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast CancerKelly K Hunt, Cansu Karakas, Min Jin Ha, et al.
Nature Communications|June 28, 2017
CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancersSmruthi Vijayaraghavan, Cansu Karakas, Iman Doostan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2023
Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing CancersTimothy P DiPeri, Kurt W Evans, Maria Gabriela Raso, et al.
Genome Research|December 24, 2017
Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesisHector L Franco, Anusha Nagari, Venkat S Malladi, et al.
Cancer Research|August 26, 2024
Low-Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast CancerMi Li, Amriti R Lulla, Yan Wang, et al.
Cancer Research|June 30, 2022
CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2Haoyan Li, Yin Wang, Kevin Lin, et al.
Cancer Research|January 5, 2023
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real TimeTuyen Duong Thanh Nguyen, Yan Wang, Tuyen N Bui, et al.
Pageof 11